Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
07-Apr-26
$1.0bn
$800mEST
n/a
On April 7, 2026, the Company's Board of Directors approved an increase of $500 million to the Company's previously authorized share repurchase program. The Repurchase Program has no expiration date and may be modified, suspended or terminated at any time.10-Q filed 09-Sep-26
24-May-24
$500m
$300mEST
n/a
On May 24, 2024, the Company's Board of Directors authorized the Company to repurchase up to $500 million of the Company's common stock pursuant to the Repurchase Program.10-Q filed 09-Sep-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)